ORIGINAL RESEARCH
Accepted on 10 Oct 2025
Metabolic Subtyping Reveals PDIK1L as a Dual-Functional Regulator of Progression and PARP Inhibitor Sensitivity in Prostate Cancer
doi 10.3389/fcell.2025.1674844
- 146 views
- Frontiers in Cell and Developmental Biology
- Cancer Cell Biology
- Research Topics
- Application of Novel Biomarkers and Natural Compounds in Precision Oncology
Application of Novel Biomarkers and Natural Compounds in Precision Oncology
4,531
Total downloads
18k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 15 Aug 2025
Identification of progression-related genes and construction of prognostic model for chronic kidney disease by machine learning
doi 10.3389/fcell.2025.1627355
- 1,077 views
ORIGINAL RESEARCH
Published on 03 Jul 2025
Multi-omics analysis of the anti-cancer effects of curcumol in endometrial carcinoma
doi 10.3389/fphar.2025.1565959
- 1,626 views
- 1 citation
ORIGINAL RESEARCH
Published on 04 Jun 2025
Mechanistic insights curcumin’s anti-inflammatory in pancreatic cancer: experimental and computational evidence implicating IL1B interference via IL10RA upregulation and NLRP3/TLR3 downregulation
doi 10.3389/fcell.2025.1601908
- 1,724 views
- 3 citations
ORIGINAL RESEARCH
Published on 23 May 2025
A dual inhibitor of TrxR1 and XIAP induces pyroptosis in melanoma
doi 10.3389/fcell.2025.1542356
- 1,136 views
ORIGINAL RESEARCH
Published on 31 Mar 2025
Pan-cancer analysis of CHRDL1 expression and its mechanistic role in inhibiting EMT via the TGF-β pathway in lung adenocarcinoma
doi 10.3389/fcell.2025.1557761
- 1,521 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Mar 2025
Spatial multi-omics analysis of tumor-stroma boundary cell features for predicting breast cancer progression and therapy response
doi 10.3389/fcell.2025.1570696
- 2,764 views
- 2 citations
REVIEW
Published on 22 Nov 2024
Blood biomarkers of hepatocellular carcinoma: a critical review
doi 10.3389/fcell.2024.1489836
- 2,343 views
- 5 citations
ORIGINAL RESEARCH
Published on 16 Sep 2024
Integrating oxidative-stress biomarkers into a precision oncology risk-stratification model for bladder cancer prognosis and therapy
doi 10.3389/fcell.2024.1453448
- 1,391 views
- 2 citations
